Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 16/20 | 0.42 |
| ▸ | AR | P10275 | 16/20 | 0.42 |
| ▸ | NR3C2 | P08235 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.38 |
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13769020 | 0.78 | PGR (0.41) | PGRARNR3C2MEN1CYP3A4 | |
| SCHEMBL4106247 | 0.77 | PGR (0.46) | PGRARNR3C2MEN1CYP3A4 | |
| SCHEMBL4107733 | 0.77 | PGR (0.46) | PGRARNR3C2MEN1CYP3A4 | |
| SCHEMBL984637 | 0.76 | PGR (0.43) | PGRARNR3C2MEN1CYP3A4 | |
| SCHEMBL985586 | 0.76 | PGR (0.43) | PGRARNR3C2MEN1CYP3A4 | |
| SCHEMBL11647236 | 0.75 | PGR (0.45) | PGRARNR3C2MEN1CYP3A4 | |
| SCHEMBL13770131 | 0.75 | AR (0.43) | PGRARNR3C2MEN1CYP3A4 | |
| SCHEMBL11643807 | 0.75 | PGR (0.45) | PGRARNR3C2MEN1CYP3A4 | |
| SCHEMBL12949547 | 0.74 | PGR (0.55) | PGRARNR3C2 | |
| SCHEMBL11644732 | 0.74 | AR (0.42) | PGRARNR3C2MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009083266-A1 | 17-HYDROXY-19-NOR-21-CARBOXYLIC ACID-STEROID γ-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING THE DERIVATIVE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-07-09 | — | — | WO | disclosed |